Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Grau-Bejar JF"'
Autor:
Perrone F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Facchinetti F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Pellegrino B; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Minari R; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Gnetti L; Pathology Unit, University Hospital of Parma, Parma, Italy., Azzoni C; Pathology Unit, University Hospital of Parma, Parma, Italy., Bottarelli L; Pathology Unit, University Hospital of Parma, Parma, Italy., Campanini N; Pathology Unit, University Hospital of Parma, Parma, Italy., Grau-Bejar JF; INSERM UMR981, Gustave Roussy Institute, Villejuif, France., Mingozzi A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Cognigni V; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, Ancona, Italy., Tiseo M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Publikováno v:
Tumori [Tumori] 2024 Dec; Vol. 110 (6), pp. NP11-NP15. Date of Electronic Publication: 2024 Jun 13.
Autor:
Grau Bejar JF; Gynecological Oncology Programme, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Gynecological Cancer Translational Research Laboratory, INSERM U981, Gustave Roussy Institute, Villejuif, France., Yaniz Galende E; Gynecological Cancer Translational Research Laboratory, INSERM U981, Gustave Roussy Institute, Villejuif, France., Zeng Q; Laboratoire d'Informatique Paris Descartes (LIPADE), Université Paris Cité, Paris, France.; Centre d'Histologie, Imagerie cellulaire et Cytométrie (CHIC), Centre de Recherche des Cordeliers, Centre de Recherche des Cordeliers, Paris, France., Genestie C; Pathology Department, Gustave Roussy Institute, Villejuif, France., Rouleau E; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy Institute, Villejuif, France., de Bruyn M; Obstetrics & Gynecology, University of Groningen Faculty of Medical Sciences, Groningen, The Netherlands., Klein C; Centre d'Histologie, Imagerie cellulaire et Cytométrie (CHIC), Centre de Recherche des Cordeliers, Centre de Recherche des Cordeliers, Paris, France., Le Formal A; Gynecological Cancer Translational Research Laboratory, INSERM U981, Gustave Roussy Institute, Villejuif, France., Edmond E; Experimental and Translational Pathology Platform (PETRA), AMMICa Inserm US23/UAR CNRS 3655, Gustave Roussy Institute, Villejuif, France., Moreau M; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy Institute, Villejuif, France., Plat A; Obstetrics & Gynecology, University of Groningen Faculty of Medical Sciences, Groningen, The Netherlands., Gouy S; Department of Gynecologic Surgery, Department of Surgery, Gustave Roussy Institute, Villejuif, France., Maulard A; Department of Gynecologic Surgery, Department of Surgery, Gustave Roussy Institute, Villejuif, France., Pautier P; Gynecological Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Michels J; Gynecological Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Oaknin A; Gynecological Oncology Programme, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Colomba-Blameble E; Gynecological Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Leary A; Gynecological Cancer Translational Research Laboratory, INSERM U981, Gustave Roussy Institute, Villejuif, France alexandra.leary@gustaveroussy.fr.; Gynecological Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 01; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 01.
Autor:
Grau-Bejar JF; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Farinas-Madrid L; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., García-Duran C; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., García-Illescas D; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Mazzeo R; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Department of Medicine, University of Udine, Udine, Italy., Oaknin A; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 Apr; Vol. 22 (3), pp. 129-139.
Autor:
Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Ghamande SA; Augusta University, Augusta, Georgia., Kasamatsu Y; Shizuoka Cancer Center, Suntogun, Japan., Gil-Martin M; Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Grau-Bejar JF; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Garcia-Duran C; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Sato M; the healthcare business of Merck KGaA, Darmstadt, Germany., Siddiqui A; the healthcare business of Merck KGaA, Darmstadt, Germany., Chaudhary SP; EMD Serono, Billerica, Massachusetts., Vugmeyster Y; EMD Serono, Billerica, Massachusetts., Hasegawa K; Saitama Medical University International Medical Center, Saitama, Japan.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 01; Vol. 30 (5), pp. 975-983.
Autor:
Grau-Bejar JF; Gynaecologic Cancer Programme Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Garcia-Duran C; Gynaecologic Cancer Programme Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Garcia-Illescas D; Gynaecologic Cancer Programme Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Mirallas O; Gynaecologic Cancer Programme Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Oaknin A; Head of Gynaecological Cancer Program, Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), P. Vall d'Hebron 119-129, Barcelona 08035, Spain.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Mar 28; Vol. 15, pp. 17588359231163836. Date of Electronic Publication: 2023 Mar 28 (Print Publication: 2023).